At MediPharm Labs (manufacturer of all Northbound Cannabis products), we are committed to manufacturing products of the highest quality that meet or exceed applicable regulatory requirements. All of our product offerings begin with high quality dried cannabis. We purchase from Canadian cannabis cultivators after they undergo our internal vendor qualification program. All received cannabis is graded against EP standards and our internal product specifications and any missing tests are conducted before being released into production. We choose suppliers based on their certification, reputation, reliability, and on their ability to deliver quality products. Reliable sources and consistent supply are critical to developing cannabis products that ensure predictable and consistent experiences for consumers. After processing, representative samples from every batch of cannabis products are tested.

All Northbound Cannabis products are formulated and manufactured at MediPharm Labs' state-of-the-art cannabis extraction facility in Barrie, Ontario, Canada, that is Good Manufacturing Practices (GMP) Certified and designed with ISO standard cleanrooms and critical environments. Our strict manufacturing standards result in pharma-quality products for patients and consumers that are pure and precisely dosable. To learn more, visit www.medipharmlabs.com

Northbound Cannabis products are manufactured by MediPharm Labs that uses Supercritical CO2 for primary extraction, and short-path wiped-film distillation for further purification and cannabinoid isolation. Learn more.

There is no hemp in any of our products, all products are cannabis derivatives.

We are sorry you are unhappy with your product. Please retain the original product and receipt, complete the Customer Service Form and our team will get back to you shortly.

If you are experiencing an adverse reaction to one of our products, seek out your medical professional as soon as possible. If it's not an emergency, please complete the Customer Service Form and we will contact you shortly.

We are actively responding to the coronavirus (COVID-19) situation by following recommendations from the local, provincial and federal authorities. We have implemented proactive measures that prioritize the health and safety of our employees, customers and partners, including: restricted work travel and site access; improved safety & hygiene; and the requirement of non-essential staff members to work remotely. As a manufacturer of medicinal cannabis products, our practice is always to operate to global pharma-quality standards within our ISO-designed ‘critical environment’ facility with strict hygiene practices and mandated personal protective equipment. We are in a heightened state of vigilance throughout this situation and will continue to monitor and respond.